CAMP · ISSUER CIK 1736730
Camp4 Therapeutics Corp
Between Jul 31, 2026 and Oct 28, 2026, 6 Camp4 Therapeutics Corp insiders reported $99K of open-market purchases and $2.5M of sales on SEC Form 4. The largest buyer was Gold Kelly (Chief Financial Officer), with $50K.
↗6 insiders filed
Original Form 4 filings from Jul 31, 2026 to Oct 28, 2026. 0 of 4 sales were reported under a 10b5-1 plan.
$99KInsider buying
$2.5MInsider selling
−$2.4MNet open-market
Sep 2, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 2, 202619:50 | Aug 31, 2026 | CAMP | Chief Financial Officer | P · Buy | $3.96 | +10,000 | 10,000 | New | +$40K | -27.2% | -7.8% |
| Aug 31, 202617:05 | Aug 27, 2026 | CAMP | Director | S · Sell | $4.04 | −400,000 | 2,033,270 | -16% | −$1.6M | ||
| Aug 26, 202616:57 | Aug 24, 2026 | CAMP | Director | S · Sell | $4.50 | −10 | 2,433,270 | -0% | −$45.00 | ||
| Aug 21, 202616:59 | Aug 21, 2026from Aug 19, 2026 | CAMP | Director | S · Sell | $4.59 | −191,865 | 2,433,280 | -7% | −$880K | ||
| Aug 19, 202620:46 | Aug 19, 2026 | CAMP | Chief Scientific Officer | S · Sell | $4.76 | −1,738 | 0 | -100% | −$8K | ||
| Aug 5, 202617:09 | Aug 3, 2026 | CAMP | Director | P · Buy | $1.65 | +16,378 | 186,388 | +10% | +$27K | -63.8% | +121.2% |
| Aug 5, 202617:08 | Aug 3, 2026 | CAMP | Chief Medical Officer | P · Buy | $1.65 | +6,551 | 12,611 | +108% | +$11K | -63.8% | +121.2% |
| Aug 5, 202617:08 | Aug 3, 2026 | CAMP | Chief Financial Officer | P · Buy | $1.65 | +6,551 | 74,428 | +10% | +$11K | -63.8% | +121.2% |
| Aug 5, 202617:07 | Aug 3, 2026 | CAMP | Chief Executive Officer, Director | P · Buy | $1.65 | +6,551 | 284,968 | +2% | +$11K | -63.8% | +121.2% |